Welcome to our dedicated page for Dlh Holdings news (Ticker: DLHC), a resource for investors and traders seeking the latest updates and insights on Dlh Holdings stock.
DLH Holdings Corp. (DLHC) provides technology-driven business process outsourcing and program management solutions for federal health and defense agencies. This news hub offers investors and stakeholders centralized access to official corporate developments and strategic initiatives.
Track all essential updates including earnings reports, federal contract awards, and technology partnerships shaping DLH's position in government health services. Our repository features verified press releases on public sector acquisitions, health IT innovations, and defense logistics programs without promotional bias.
Key updates cover DLH's work with agencies like the Department of Veterans Affairs and Defense Health Agency, emphasizing their digital transformation initiatives in telehealth and analytics. Users gain insights into operational milestones through primary source documents and objective reporting.
Bookmark this page for streamlined monitoring of DLHC's evolving role in federal healthcare solutions. Check regularly for new developments affecting government contracting strategies and public health program management.
DLH Holdings Corp. (NASDAQ: DLHC) reported its financial results for the fiscal fourth quarter ending September 30, 2022, revealing a 3% year-over-year revenue increase to $67.2 million and $395.2 million for the full fiscal year, boosted by FEMA contracts. Earnings per share rose to $0.24 in Q4 and $1.64 for the year. Debt was reduced to $22.0 million from $46.8 million. The company maintains a substantial contract backlog of $482.5 million, positioning it well for future growth amid ongoing demand for its services.
DLH Holdings Corp. (NASDAQ: DLHC) has announced its participation in the Truist Industrials & Services Summit on December 6, 2022, at the JW Marriott Essex House Hotel in New York. The event will feature one-on-one meetings with management, allowing institutional investors to engage directly. A presentation will also be accessible on the Company’s website.
DLH is dedicated to providing healthcare and human services solutions to federal government programs, with over 2,300 employees committed to public health innovation.
DLH Holdings Corp. (NASDAQ: DLHC) will report its financial results for the fiscal fourth quarter ending September 30, 2022, on December 5, 2022, before market opening. The company will host a conference call at 10:00 a.m. ET the same day, where senior management will present financial results and operational trends, followed by a Q&A session. Interested stakeholders can listen in by dialing the provided numbers, and materials will be accessible on their Investor Relations website. DLH focuses on innovative health and readiness solutions for federal programs.
DLH Holdings Corp. (NASDAQ: DLHC) has announced that the Department of Veterans Affairs' Consolidated Mail Order Pharmacy (CMOP) program achieved the highest customer satisfaction rating in J.D. Power's 2022 U.S. Pharmacy Study. CEO Zach Parker emphasized the program's ability to maintain this satisfaction despite challenges like labor market issues and inflation. The study is based on thousands of customer responses and reinforces DLH's commitment to providing essential services to Veterans.
DLH Holdings Corp. (NASDAQ: DLHC) has secured an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with the Department of Veteran Affairs (VA) aimed at enhancing healthcare innovations. This contract, part of the Accelerating VA Innovation and Learning (AVAIL) initiative, features a five-year base period with a ceiling of $650 million across 17 competitors. DLH will utilize its expertise in digital health tools and advanced technologies to support Veterans with improved care solutions.
DLH Holdings Corp. (NASDAQ: DLHC) reported fiscal Q3 2022 results with revenue of $66.4 million, an 8% increase year-over-year. Earnings rose to $4.9 million, or $0.34 per diluted share, up from $2.9 million or $0.21 per diluted share in Q3 2021. The operating margin improved to 10.7% from 8.0%. Debt was reduced to $28.5 million, down from $37.5 million. Contract backlog stood at $509.7 million as of June 30, 2022. The company secured two major contracts with federal agencies, enhancing its growth prospects for fiscal 2023.
DLH Holdings Corp. (NASDAQ: DLHC) is set to release its fiscal third-quarter financial results on August 2, 2022. The results will cover the period ended June 30, 2022. Following the financial release, a conference call is scheduled for August 3, 2022, at 10:00 a.m. ET, where senior management will discuss the results and operational trends. Interested parties can participate via phone or access the presentation materials on the Investor Relations section of the DLH website. A digital recording of the call will be available afterward.
DLH Holdings Corp. (NASDAQ: DLHC) announced that its subsidiary, Social & Scientific Systems, Inc., secured an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with the National Cancer Institute (NCI). This contract allows DLH to support cancer research in various task areas including study management and biospecimen activities, with a potential ceiling of $320 million over ten years. The contract replaces previous NCI agreements and positions DLH to enhance its public health missions, particularly in cancer prevention and research.
DLH Holdings Corp. (NASDAQ: DLHC) announced a new contract with the National Institute of Environmental Health Sciences (NIEHS) to provide statistical, mathematical, and computational support. This award, valued at approximately $13 million, spans one year with four additional one-year options. DLH will deliver software programming, research support, and data visualization focusing on areas like carcinogenesis and toxicology. The contract continuation highlights DLH's strong partnership with NIEHS, showcasing its expertise in public health and scientific research.
FAQ
What is the current stock price of Dlh Holdings (DLHC)?
What is the market cap of Dlh Holdings (DLHC)?
